391 related articles for article (PubMed ID: 28903345)
1. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.
Heverhagen AE; Legrand N; Wagner V; Fendrich V; Bartsch DK; Slater EP
Neuroendocrinology; 2018; 106(4):312-317. PubMed ID: 28848144
[TBL] [Abstract][Full Text] [Related]
3. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
[TBL] [Abstract][Full Text] [Related]
5. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.
Tay JW; James I; Hughes QW; Tiao JY; Baker RI
BMC Res Notes; 2017 Jul; 10(1):312. PubMed ID: 28743297
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction.
Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F
Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325
[TBL] [Abstract][Full Text] [Related]
8. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
Wang KJ; Zhao X; Liu YZ; Zeng QT; Mao XB; Li SN; Zhang M; Jiang C; Zhou Y; Qian C; Feng KG; Guan HQ; Tang TT; Cheng X; Chen ZJ
Cell Physiol Biochem; 2016; 38(3):1015-29. PubMed ID: 26939053
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer.
Mazza T; Gioffreda D; Fontana A; Biagini T; Carella M; Palumbo O; Maiello E; Bazzocchi F; Andriulli A; Tavano F
Front Oncol; 2020; 10():44. PubMed ID: 32117716
[TBL] [Abstract][Full Text] [Related]
10. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
[TBL] [Abstract][Full Text] [Related]
12. [Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].
Trukhina DA; Mamedova EO; Nikitin AG; Koshkin PA; Belaya ZE; Melnichenko GA
Probl Endokrinol (Mosk); 2024 Jan; 69(6):70-85. PubMed ID: 38311997
[TBL] [Abstract][Full Text] [Related]
13. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530
[TBL] [Abstract][Full Text] [Related]
14. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
Front Genet; 2020; 11():449. PubMed ID: 32508877
[No Abstract] [Full Text] [Related]
15. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
[TBL] [Abstract][Full Text] [Related]
17. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients.
Muendlein A; Geiger K; Leiherer A; Saely CH; Fraunberger P; Drexel H
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F315-F321. PubMed ID: 31813253
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Mlcochova J; Faltejskova-Vychytilova P; Ferracin M; Zagatti B; Radova L; Svoboda M; Nemecek R; John S; Kiss I; Vyzula R; Negrini M; Slaby O
Oncotarget; 2015 Nov; 6(36):38695-704. PubMed ID: 26497852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]